Foamix Pharmaceuticals Ltd. Accounts Receivable, Allowance for Credit Loss, Current
Foamix Pharmaceuticals Ltd. had Accounts Receivable, Allowance for Credit Loss, Current of $0 as of 2019-12-31, per its 10-K filed 2020-03-12.
Discontinued › Balance Sheet › Assets › Assets, Current › Receivables, Net, Current › Accounts Receivable, after Allowance for Credit Loss, Current
us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent · last filed 2020-03-12
- 2019-12-31: Accounts Receivable, Allowance for Credit Loss, Current $0.00.
- 2018-12-31: Accounts Receivable, Allowance for Credit Loss, Current $0.00.
- 2017-12-31: Accounts Receivable, Allowance for Credit Loss, Current $0.00.
- 2016-12-31: Accounts Receivable, Allowance for Credit Loss, Current $0.00.
| Period end | Accounts Receivable, Allowance for Credit Loss, Current |
|---|---|
| 2019-12-31 | $0.00 10-K · filed 2020-03-12 |
| 2018-12-31 | $0.00 10-K · filed 2020-03-12 |
| 2017-12-31 | $0.00 10-K · filed 2020-03-12 |
| 2016-12-31 | $0.00 10-K · filed 2019-02-28 |
| 2015-12-31 | $0.00 10-K · filed 2018-03-01 |
| 2014-12-31 | $0.00 20-F · filed 2016-03-02 |
| 2013-12-31 | $0.00 20-F · filed 2015-03-17 |